MicroRNA-29b Suppresses Inflammation and Protects Blood-Brain Barrier Integrity in Ischemic Stroke

Objectives. Following cerebral ischemia, microRNA- (miR-) 29b in circulating blood is downregulated. This study investigates the underlying mechanism and implications of miR-29b in leukocyte induction. Methods. miR-29b from stroke patients and rats with middle cerebral artery occlusion (MCAO) were a...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoqing Ma, Ho Jun Yun, Kenneth Elkin, Yunliang Guo, Yuchuan Ding, Guangwen Li
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2022/1755416
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562173686054912
author Xiaoqing Ma
Ho Jun Yun
Kenneth Elkin
Yunliang Guo
Yuchuan Ding
Guangwen Li
author_facet Xiaoqing Ma
Ho Jun Yun
Kenneth Elkin
Yunliang Guo
Yuchuan Ding
Guangwen Li
author_sort Xiaoqing Ma
collection DOAJ
description Objectives. Following cerebral ischemia, microRNA- (miR-) 29b in circulating blood is downregulated. This study investigates the underlying mechanism and implications of miR-29b in leukocyte induction. Methods. miR-29b from stroke patients and rats with middle cerebral artery occlusion (MCAO) were assessed using real-time polymerase chain reaction (PCR). miR-29b agomir was used to increase miR-29b expression in leukocytes via intravenous injection. C1q and tumor necrosis factor (C1QTNF) 6, interleukin- (IL-) 1β, zonula occludens- (ZO-) 1, occludin, and ischemic outcomes were assessed in MCAO rats. Additionally, hCMEC/D3 cells were subjected to oxygen–glucose deprivation (OGD) and cocultured with HL-60 cells. Results. miR-29b levels in neutrophils were found to be significantly lower in stroke patients compared with healthy controls, which may indicate its high diagnostic sensitivity and specificity for stroke. Moreover, miR-29b levels in leukocytes showed a negative correlation with National Institute of Health Stroke Scale (NIHSS) scores and C1QTNF6 levels. In MCAO rats, miR-29b overexpression reduced brain infarct volume and brain edema, decreasing IL-1β levels in leukocytes and in the brain 24 hours poststroke. miR-29b attenuated IL-1β expression via C1QTNF6 inhibition, leading to decreased blood-brain barrier (BBB) disruption and leukocyte infiltration. Moreover, miR-29b overexpression in HL-60 cells downregulated OGD-induced hCMEC/D3 cell apoptosis and increased ZO-1 and occludin levels in vitro. Conclusion. Leukocytic miR-29b attenuates inflammatory response by augmenting BBB integrity through C1QTNF6, suggesting a novel miR-29b-based therapeutic therapy for ischemic stroke.
format Article
id doaj-art-2ef3017857cd45e292bb594c486780fe
institution Kabale University
issn 1466-1861
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-2ef3017857cd45e292bb594c486780fe2025-02-03T01:23:11ZengWileyMediators of Inflammation1466-18612022-01-01202210.1155/2022/1755416MicroRNA-29b Suppresses Inflammation and Protects Blood-Brain Barrier Integrity in Ischemic StrokeXiaoqing Ma0Ho Jun Yun1Kenneth Elkin2Yunliang Guo3Yuchuan Ding4Guangwen Li5Department of NeurologyWayne State University School of MedicineWayne State University School of MedicineDepartment of NeurologyDepartment of NeurosurgeryDepartment of NeurologyObjectives. Following cerebral ischemia, microRNA- (miR-) 29b in circulating blood is downregulated. This study investigates the underlying mechanism and implications of miR-29b in leukocyte induction. Methods. miR-29b from stroke patients and rats with middle cerebral artery occlusion (MCAO) were assessed using real-time polymerase chain reaction (PCR). miR-29b agomir was used to increase miR-29b expression in leukocytes via intravenous injection. C1q and tumor necrosis factor (C1QTNF) 6, interleukin- (IL-) 1β, zonula occludens- (ZO-) 1, occludin, and ischemic outcomes were assessed in MCAO rats. Additionally, hCMEC/D3 cells were subjected to oxygen–glucose deprivation (OGD) and cocultured with HL-60 cells. Results. miR-29b levels in neutrophils were found to be significantly lower in stroke patients compared with healthy controls, which may indicate its high diagnostic sensitivity and specificity for stroke. Moreover, miR-29b levels in leukocytes showed a negative correlation with National Institute of Health Stroke Scale (NIHSS) scores and C1QTNF6 levels. In MCAO rats, miR-29b overexpression reduced brain infarct volume and brain edema, decreasing IL-1β levels in leukocytes and in the brain 24 hours poststroke. miR-29b attenuated IL-1β expression via C1QTNF6 inhibition, leading to decreased blood-brain barrier (BBB) disruption and leukocyte infiltration. Moreover, miR-29b overexpression in HL-60 cells downregulated OGD-induced hCMEC/D3 cell apoptosis and increased ZO-1 and occludin levels in vitro. Conclusion. Leukocytic miR-29b attenuates inflammatory response by augmenting BBB integrity through C1QTNF6, suggesting a novel miR-29b-based therapeutic therapy for ischemic stroke.http://dx.doi.org/10.1155/2022/1755416
spellingShingle Xiaoqing Ma
Ho Jun Yun
Kenneth Elkin
Yunliang Guo
Yuchuan Ding
Guangwen Li
MicroRNA-29b Suppresses Inflammation and Protects Blood-Brain Barrier Integrity in Ischemic Stroke
Mediators of Inflammation
title MicroRNA-29b Suppresses Inflammation and Protects Blood-Brain Barrier Integrity in Ischemic Stroke
title_full MicroRNA-29b Suppresses Inflammation and Protects Blood-Brain Barrier Integrity in Ischemic Stroke
title_fullStr MicroRNA-29b Suppresses Inflammation and Protects Blood-Brain Barrier Integrity in Ischemic Stroke
title_full_unstemmed MicroRNA-29b Suppresses Inflammation and Protects Blood-Brain Barrier Integrity in Ischemic Stroke
title_short MicroRNA-29b Suppresses Inflammation and Protects Blood-Brain Barrier Integrity in Ischemic Stroke
title_sort microrna 29b suppresses inflammation and protects blood brain barrier integrity in ischemic stroke
url http://dx.doi.org/10.1155/2022/1755416
work_keys_str_mv AT xiaoqingma microrna29bsuppressesinflammationandprotectsbloodbrainbarrierintegrityinischemicstroke
AT hojunyun microrna29bsuppressesinflammationandprotectsbloodbrainbarrierintegrityinischemicstroke
AT kennethelkin microrna29bsuppressesinflammationandprotectsbloodbrainbarrierintegrityinischemicstroke
AT yunliangguo microrna29bsuppressesinflammationandprotectsbloodbrainbarrierintegrityinischemicstroke
AT yuchuanding microrna29bsuppressesinflammationandprotectsbloodbrainbarrierintegrityinischemicstroke
AT guangwenli microrna29bsuppressesinflammationandprotectsbloodbrainbarrierintegrityinischemicstroke